Doctor explains study showing GLP-1s may lower breast cancer risk

The study on GLP-1 medications, commonly used for weight management and diabetes, found a significant correlation with a lower risk of breast cancer among women aged 45 to 80. Women on these drugs showed a 30% reduction in breast cancer risk, suggesting a potential protective effect beyond their primary uses. This matters because it opens up new avenues for cancer prevention strategies, especially for those already using GLP-1s. The findings could lead to broader recommendations and further research to understand the underlying mechanisms.